Imaging research centers across the U.S. will get more than half of nearly $22 million earmarked by the National Institutes of Health this year for grants to fund cutting-edge biomedical research equipment purchases.
Imaging research centers across the U.S. will get more than half of nearly $22 million earmarked by the National Institutes of Health this year for grants to fund cutting-edge biomedical research equipment purchases.
The NIH's National Center for Research Resources began the High-End Instrumentation (HEI) program in 2002. The HEI allows research institutions to acquire equipment costing between $750,000 and $2 million. It complements the NCRR's long-standing Shared Instrumentation Grant program supporting the purchase of equipment in the $100,000 to $500,000 price range.
The HEI program provides numerous investigators access to equipment that is essential to advance their research projects. It often benefits entire research communities as well, said Dr. Barbara M. Alving, NCRR's acting director.
"These awards spur the kind of scientific discoveries necessary for the development of treatments for a broad spectrum of diseases," Alving said.
The NCRR announced in August it will provide $21.5 million during the 2006 fiscal year for 14 HEI grants. Awardees include the following diagnostic imaging research centers:
The HEI provides a one-year nonrenewable award for the purchase of one major equipment item per application. The program may fund three or more investigators per institution needing instrumentation such as biomedical imaging equipment, NMR mass spectrometers, electron microscopes, or supercomputers.
The NCRR does not require matching funds but expects applicants to provide adequate support for the infrastructure associated to their purchase.
For more information from the Diagnostic Imaging archives:
Biomedical research in Oregon gets boost from 12T MR scanner
Focused ultrasound ablation goes after brain tumors
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.